[1]
Heng, D. 2015. Third-line treatment in metastatic renal cell carcinoma and bone metastases. Canadian Urological Association Journal. 9, 7-8 (Aug. 2015), 268. DOI:https://doi.org/10.5489/cuaj.3238.